AtriCure (ATRC) Tops Q4 EPS by 9c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $28.51 -1.01%
Revenue Growth %: +11.7%
Financial Fact:
Selling, general and administrative expenses: 25.49M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +11.7%
Financial Fact:
Selling, general and administrative expenses: 25.49M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q4 EPS of ($0.09), $0.09 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $88 million versus the consensus estimate of $87.77 million.
GUIDANCE:
AtriCure sees FY2023 revenue of $380-387 million, versus the consensus of $381.7 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- AeroVironment restates quarterly financials, citing $89M goodwill error
- CRH agrees to buy Arcosa in $8.5B all-cash deal
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
